SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
I-Mab (IMAB) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 59/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IMAB
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-4.46
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-5.13 |
$11.56M |
$-298.24M |
-2580.8% |
| 2018 |
$-6.92 |
$53.78M |
$-402.83M |
-749% |
| 2019 |
$-25.53 |
$30M |
$-1.49B |
-4950% |
| 2020 |
$6.90 |
$1.54B |
$470.92M |
30.5% |
| 2021 |
$-30.69 |
$88.03M |
$-2.33B |
-2648.7% |
| 2022 |
$-30.39 |
$-221.56M |
$-2.51B |
- |
| 2023 |
$-17.61 |
$27.64M |
$-1.47B |
-5302% |
| 2024 |
$-4.46 |
$0.00 |
$-162.26M |
- |
